Related Experiment Video
Updated: Oct 1, 2025
08:05
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
14.4K
What Do We Talk About Now When We Talk About Segmentectomy for GGO?
Hanyue Li1, Chen Shen1, Yang Chen1
1Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.
Frontiers in Surgery
|March 4, 2022
Summary
Segmentectomy may offer similar cancer control to lobectomy for early lung cancers with ground glass opacity. Further research is needed to confirm its benefits in reducing surgical risks and preserving lung function.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Pulmonary Medicine
Background:
- Lung cancers are increasingly detected at earlier stages via computed tomography (CT) screening, often as ground glass opacity (GGO) lesions.
- GGO-containing lung cancers are typically indolent with minimal lymphatic spread, making them suitable for less invasive surgical approaches.
- Segmentectomy, a less extensive lung resection, is being reconsidered for early-stage lung cancer, particularly GGO-containing types.
Purpose of the Study:
- To reevaluate the efficacy of minimally invasive segmentectomy compared to lobectomy for GGO-containing lung cancers.
- To assess oncological outcomes, perioperative results, and pulmonary function changes associated with segmentectomy versus lobectomy.
- To determine if segmentectomy can reduce risks and preserve lung function without compromising cancer control in selected patients.
Main Methods:
- Comparative analysis of outcomes between segmentectomy and lobectomy for GGO-containing lung cancers.
- Focus on minimally invasive surgical approaches.
- Evaluation of oncological results, perioperative complications, and postoperative pulmonary function.
Main Results:
- Emerging evidence suggests segmentectomy may achieve oncological non-inferiority to lobectomy for GGO lesions, potentially beyond 2 cm.
- The extent to which segmentectomy minimizes perioperative risks and preserves pulmonary function requires further investigation.
- Robust evidence is still needed to definitively establish the benefits of segmentectomy in the context of minimally invasive surgery for these specific lung cancers.
Conclusions:
- Minimally invasive segmentectomy warrants further investigation as a viable alternative to lobectomy for select early-stage lung cancers with GGO.
- More clinical trials are essential to validate the oncological safety, perioperative advantages, and functional benefits of segmentectomy.
- Future research should focus on robust evidence to support the combination of segmentectomy and minimally invasive surgery for improved patient outcomes.
